1-(tert-butyl) 2-ethyl (2S,5S)-5-hydroxypiperidine-1,2-dicarboxylate

Catalog No. :
ACTPAZ157
CAS No. :
2490154-99-7
Molecular Formula :
C13H23NO5
Molecular Weight :
273.33

IUPAC Name:1-(tert-butyl) 2-ethyl (2S,5S)-5-hydroxypiperidine-1,2-dicarboxylate

1-(tert-butyl) 2-ethyl (2S,5S)-5-hydroxypiperidine-1,2-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$387.00Login to see priceIn stockInquiry
250mg97%$646.00Login to see priceIn stockInquiry
500mg97%$921.00Login to see priceIn stockInquiry
1g97%$1316.00Login to see priceIn stockInquiry
5g97%$3947.00Login to see priceIn stockInquiry
10g97%$6710.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-butyl) 2-ethyl (2S,5S)-5-hydroxypiperidine-1,2-dicarboxylate
IUPAC Name1-(tert-butyl) 2-ethyl (2S,5S)-5-hydroxypiperidine-1,2-dicarboxylate
Molecular FormulaC13H23NO5
Molecular Weight273.33
SMILESO=C(N1[C@H](C(OCC)=O)CC[C@H](O)C1)OC(C)(C)C
InChI KeyQXPPPWXTNBWACT-UWVGGRQHSA-N
Synonym1,2-Piperidinedicarboxylic acid, 5-hydroxy-, 1-(1,1-dimethylethyl) 2-ethyl ester, (2R,5R)-rel-;O1-tert-butyl O2-ethyl cis-5-hydroxypiperidine-1,2-dicarboxylate;O1-tert-butyl O2-ethyl cis-5-hydroxypiperidine-1,2-dicarboxylate - [B85923]
CAS No.2490154-99-7
PubChem CID118193113

Synthetic Route by SureRoute

1. ACTPAZ157 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTPAZ157 route product structure diagram
    ACTPAZ1572490154-99-7 In Stock
Inquiry

2. ACTPAZ157 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTPAZ157 route product structure diagram
    ACTPAZ1572490154-99-7 In Stock
Inquiry

Comments (0)